JP2005504532A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504532A5 JP2005504532A5 JP2003525596A JP2003525596A JP2005504532A5 JP 2005504532 A5 JP2005504532 A5 JP 2005504532A5 JP 2003525596 A JP2003525596 A JP 2003525596A JP 2003525596 A JP2003525596 A JP 2003525596A JP 2005504532 A5 JP2005504532 A5 JP 2005504532A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament according
- medicament
- cancer
- antagonist
- endothelial cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 21
- 239000005557 antagonist Substances 0.000 claims 9
- 210000002889 endothelial cell Anatomy 0.000 claims 8
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 230000000365 steroidogenetic effect Effects 0.000 claims 4
- 208000026062 Tissue disease Diseases 0.000 claims 3
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 3
- 230000033115 angiogenesis Effects 0.000 claims 3
- 230000004663 cell proliferation Effects 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 230000001850 reproductive effect Effects 0.000 claims 3
- 230000004083 survival effect Effects 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 230000001419 dependent effect Effects 0.000 claims 2
- 230000035558 fertility Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 210000000056 organ Anatomy 0.000 claims 2
- 210000001550 testis Anatomy 0.000 claims 2
- 208000034431 Adrenal hypoplasia congenita Diseases 0.000 claims 1
- 208000005676 Adrenogenital syndrome Diseases 0.000 claims 1
- 208000005875 Alternating hemiplegia of childhood Diseases 0.000 claims 1
- 208000008448 Congenital adrenal hyperplasia Diseases 0.000 claims 1
- 208000010255 Familial Hypoadrenocorticism Diseases 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- 206010059594 Secondary hypogonadism Diseases 0.000 claims 1
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 1
- 206010057644 Testis cancer Diseases 0.000 claims 1
- 208000002495 Uterine Neoplasms Diseases 0.000 claims 1
- 201000010869 X-linked adrenal hypoplasia congenita Diseases 0.000 claims 1
- 239000003098 androgen Substances 0.000 claims 1
- 210000003372 endocrine gland Anatomy 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 208000000509 infertility Diseases 0.000 claims 1
- 230000036512 infertility Effects 0.000 claims 1
- 231100000535 infertility Toxicity 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 201000007700 organ system cancer Diseases 0.000 claims 1
- 208000001061 polyostotic fibrous dysplasia Diseases 0.000 claims 1
- 208000006155 precocious puberty Diseases 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 230000035938 sexual maturation Effects 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 201000003120 testicular cancer Diseases 0.000 claims 1
- 206010046766 uterine cancer Diseases 0.000 claims 1
- 210000004291 uterus Anatomy 0.000 claims 1
- 210000003556 vascular endothelial cell Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31618401P | 2001-08-29 | 2001-08-29 | |
| PCT/US2002/027571 WO2003020892A2 (en) | 2001-08-29 | 2002-08-27 | Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005504532A JP2005504532A (ja) | 2005-02-17 |
| JP2005504532A5 true JP2005504532A5 (enExample) | 2006-01-05 |
| JP4361791B2 JP4361791B2 (ja) | 2009-11-11 |
Family
ID=23227889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003525596A Expired - Fee Related JP4361791B2 (ja) | 2001-08-29 | 2002-08-27 | マイトジェン活性を有するＢｖ８核酸及びポリペプチド |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US7060278B2 (enExample) |
| EP (2) | EP1427830B1 (enExample) |
| JP (1) | JP4361791B2 (enExample) |
| KR (3) | KR101008734B1 (enExample) |
| CN (2) | CN101884784B (enExample) |
| AT (1) | ATE557092T1 (enExample) |
| AU (1) | AU2002332732B2 (enExample) |
| BR (1) | BR0212070A (enExample) |
| CA (1) | CA2458670C (enExample) |
| DK (1) | DK1427830T3 (enExample) |
| ES (1) | ES2386346T3 (enExample) |
| HU (1) | HU230373B1 (enExample) |
| IL (4) | IL160422A0 (enExample) |
| IS (1) | IS2889B (enExample) |
| MX (1) | MXPA04001720A (enExample) |
| NO (2) | NO332445B1 (enExample) |
| NZ (2) | NZ543755A (enExample) |
| PL (1) | PL368972A1 (enExample) |
| SI (1) | SI1427830T1 (enExample) |
| WO (1) | WO2003020892A2 (enExample) |
| ZA (1) | ZA200401001B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101008734B1 (ko) * | 2001-08-29 | 2011-01-14 | 제넨테크, 인크. | 유사분열촉진 활성을 가진 Ｂｖ８ 핵산 및 폴리펩티드 |
| WO2003040326A2 (en) * | 2001-11-02 | 2003-05-15 | Nuvelo, Inc. | Methods and materials relating to prokineticin-like polypeptides and polynucleotides |
| JP4912144B2 (ja) * | 2003-03-12 | 2012-04-11 | ジェネンテック， インコーポレイテッド | 造血促進のためのｂｖ８及び／又はｅｇ−ｖｅｇｆの使用 |
| GB0320238D0 (en) | 2003-08-29 | 2003-10-01 | Medical Res Council | Treatment of disease |
| EP1689849A4 (en) * | 2003-10-31 | 2008-06-25 | Univ California | PROCINETICIN AND PROKINETICIN RECEPTOR POLYPEPTIDES FROM PRIMATES, COMPOSITIONS AND METHODS ASSEMBLED THEREWITH |
| EP1756153A2 (en) * | 2004-03-29 | 2007-02-28 | Janssen Pharmaceutica N.V. | Prokineticin 2beta peptide and its use |
| US7872430B2 (en) * | 2005-11-18 | 2011-01-18 | Cree, Inc. | Solid state lighting panels with variable voltage boost current sources |
| US20070243584A1 (en) * | 2006-04-13 | 2007-10-18 | West James W | Tetramerizing polypeptides and methods of use |
| EP2004682A2 (en) * | 2006-04-13 | 2008-12-24 | Zymogenetics, Inc. | Tetramerizing polypeptides and methods of use |
| US20100075377A1 (en) * | 2006-04-13 | 2010-03-25 | West James W | Tetramerizing polypeptides and methods of use |
| CL2008002782A1 (es) * | 2007-09-21 | 2009-07-31 | Genentech Inc | Anticuerpo anti-bv8 neutralizante; composicion que lo comprende; y su uso para tratar tumores en humanos previamente tratados con un antagonista del factor de crecimiento endotelial vascular. |
| KR101044874B1 (ko) * | 2008-12-02 | 2011-06-28 | 주식회사 동호 | 흡인식 쓰레기 설비의 이송관로 막힘 검출 시스템 |
| EP2516465B1 (en) | 2009-12-23 | 2016-05-18 | F.Hoffmann-La Roche Ag | Anti-bv8 antibodies and uses thereof |
| KR101040724B1 (ko) * | 2010-08-16 | 2011-06-10 | 주식회사 에스더블 테크 | 공기이송 더스트 배출장치 |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4109496A (en) | 1977-12-20 | 1978-08-29 | Norris Industries | Trapped key mechanism |
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| EP0052322B1 (de) | 1980-11-10 | 1985-03-27 | Gersonde, Klaus, Prof. Dr. | Verfahren zur Herstellung von Lipid-Vesikeln durch Ultraschallbehandlung, Anwendung des Verfahrens und Vorrichtung zur Durchführung des Verfahrens |
| US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| DE3374837D1 (en) | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| US4943529A (en) | 1982-05-19 | 1990-07-24 | Gist-Brocades Nv | Kluyveromyces as a host strain |
| EP0102324A3 (de) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
| US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
| AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| AU3145184A (en) | 1983-08-16 | 1985-02-21 | Zymogenetics Inc. | High expression of foreign genes in schizosaccharomyces pombe |
| DE3483949D1 (de) | 1983-09-26 | 1991-02-21 | Udo Dr Med Ehrenfeld | Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr. |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| EP0143949B1 (en) | 1983-11-01 | 1988-10-12 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Pharmaceutical composition containing urokinase |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| EP0272253A4 (en) | 1986-03-07 | 1990-02-05 | Massachusetts Inst Technology | METHOD FOR IMPROVING GLYCOPROTE INSTABILITY. |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US4946783A (en) | 1987-01-30 | 1990-08-07 | President And Fellows Of Harvard College | Periplasmic protease mutants of Escherichia coli |
| US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
| IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
| GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
| EP0321196A3 (en) | 1987-12-18 | 1990-07-18 | Mycogen Plant Science, Inc. | 780 t-dna gene transcription activator |
| JPH04501201A (ja) | 1987-12-21 | 1992-03-05 | ジ・アップジョン・カンパニー | 発芽植物種子類のアグロバクテリウム媒介形質転換 |
| AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
| EP0435911B1 (en) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| US5240848A (en) | 1988-11-21 | 1993-08-31 | Monsanto Company | Dna sequences encoding human vascular permeability factor having 189 amino acids |
| US5116964A (en) | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| DE394538T1 (de) | 1989-04-28 | 1991-04-11 | Rhein Biotech Ges. Fuer Biotechnologische Prozesse Und Produkte Mbh, 4000 Duesseldorf | Hefezellen der schwanniomyces-gattung. |
| US5332671A (en) | 1989-05-12 | 1994-07-26 | Genetech, Inc. | Production of vascular endothelial cell growth factor and DNA encoding same |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| ATE144793T1 (de) | 1989-06-29 | 1996-11-15 | Medarex Inc | Bispezifische reagenzien für die aids-therapie |
| DK168302B1 (da) | 1989-06-29 | 1994-03-07 | Danisco | Fremgangsmåde til indføring af molekyler, især genetisk materiale i planteceller |
| FR2649120B1 (fr) | 1989-06-30 | 1994-01-28 | Cayla | Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede |
| CA2068204C (en) | 1989-11-22 | 2002-02-12 | Arthur Levinson | Latency associated peptides and uses therefor |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
| WO1992020373A1 (en) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
| JP3540315B2 (ja) | 1991-09-23 | 2004-07-07 | メディカル リサーチ カウンシル | キメラ抗体の製造−組合せアプローチ |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| AU3178993A (en) | 1991-11-25 | 1993-06-28 | Enzon, Inc. | Multivalent antigen-binding proteins |
| ATE149570T1 (de) | 1992-08-17 | 1997-03-15 | Genentech Inc | Bispezifische immunoadhesine |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| AUPM425294A0 (en) * | 1994-03-04 | 1994-03-31 | Australian National University, The | In-vitro angiogenesis assay |
| US5561053A (en) | 1994-08-05 | 1996-10-01 | Genentech, Inc. | Method for selecting high-expressing host cells |
| US6013780A (en) | 1996-09-06 | 2000-01-11 | Technion Research & Development Co. Ltd. | VEGF145 expression vectors |
| US20020172678A1 (en) | 2000-06-23 | 2002-11-21 | Napoleone Ferrara | EG-VEGF nucleic acids and polypeptides and methods of use |
| WO2001036465A2 (en) * | 1999-11-16 | 2001-05-25 | Zymogenetics, Inc. | Human zven proteins |
| JP2004532609A (ja) * | 2000-11-03 | 2004-10-28 | ザ リージェント オブ ザ ユニバーシティ オブ カリフォルニア | プロキネチシンポリペプチド、関連組成物および方法 |
| KR101008734B1 (ko) * | 2001-08-29 | 2011-01-14 | 제넨테크, 인크. | 유사분열촉진 활성을 가진 Ｂｖ８ 핵산 및 폴리펩티드 |
| JP4912144B2 (ja) | 2003-03-12 | 2012-04-11 | ジェネンテック， インコーポレイテッド | 造血促進のためのｂｖ８及び／又はｅｇ−ｖｅｇｆの使用 |
| CL2008002782A1 (es) * | 2007-09-21 | 2009-07-31 | Genentech Inc | Anticuerpo anti-bv8 neutralizante; composicion que lo comprende; y su uso para tratar tumores en humanos previamente tratados con un antagonista del factor de crecimiento endotelial vascular. |
-
2002
- 2002-08-27 KR KR1020097012101A patent/KR101008734B1/ko not_active Expired - Fee Related
- 2002-08-27 EP EP02797786A patent/EP1427830B1/en not_active Expired - Lifetime
- 2002-08-27 JP JP2003525596A patent/JP4361791B2/ja not_active Expired - Fee Related
- 2002-08-27 HU HU0401584A patent/HU230373B1/hu not_active IP Right Cessation
- 2002-08-27 KR KR1020047002640A patent/KR100942880B1/ko not_active Expired - Fee Related
- 2002-08-27 KR KR1020107002333A patent/KR101008785B1/ko not_active Expired - Fee Related
- 2002-08-27 NZ NZ543755A patent/NZ543755A/en not_active IP Right Cessation
- 2002-08-27 AT AT02797786T patent/ATE557092T1/de active
- 2002-08-27 ES ES02797786T patent/ES2386346T3/es not_active Expired - Lifetime
- 2002-08-27 AU AU2002332732A patent/AU2002332732B2/en not_active Ceased
- 2002-08-27 WO PCT/US2002/027571 patent/WO2003020892A2/en not_active Ceased
- 2002-08-27 SI SI200230990T patent/SI1427830T1/sl unknown
- 2002-08-27 US US10/231,411 patent/US7060278B2/en not_active Expired - Lifetime
- 2002-08-27 NZ NZ530985A patent/NZ530985A/xx not_active IP Right Cessation
- 2002-08-27 CN CN201010227537.3A patent/CN101884784B/zh not_active Expired - Fee Related
- 2002-08-27 BR BR0212070-4A patent/BR0212070A/pt not_active Application Discontinuation
- 2002-08-27 CN CN028209664A patent/CN1575338B/zh not_active Expired - Fee Related
- 2002-08-27 MX MXPA04001720A patent/MXPA04001720A/es active IP Right Grant
- 2002-08-27 EP EP10009859A patent/EP2311960A3/en not_active Withdrawn
- 2002-08-27 PL PL02368972A patent/PL368972A1/xx not_active Application Discontinuation
- 2002-08-27 CA CA2458670A patent/CA2458670C/en not_active Expired - Fee Related
- 2002-08-27 DK DK02797786.7T patent/DK1427830T3/da active
- 2002-08-27 IL IL16042202A patent/IL160422A0/xx unknown
-
2004
- 2004-02-06 NO NO20040553A patent/NO332445B1/no not_active IP Right Cessation
- 2004-02-06 ZA ZA200401001A patent/ZA200401001B/en unknown
- 2004-02-13 IS IS7154A patent/IS2889B/is unknown
- 2004-02-16 IL IL160422A patent/IL160422A/en not_active IP Right Cessation
-
2006
- 2006-03-17 US US11/384,222 patent/US20060204510A1/en not_active Abandoned
- 2006-09-29 US US11/536,880 patent/US7811984B2/en not_active Expired - Fee Related
-
2009
- 2009-03-11 IL IL197539A patent/IL197539A/en not_active IP Right Cessation
-
2010
- 2010-03-16 IL IL204543A patent/IL204543A/en not_active IP Right Cessation
-
2012
- 2012-05-24 NO NO20120612A patent/NO334713B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005504532A5 (enExample) | ||
| JP7440581B2 (ja) | 抗炎症活性を有するペプチド、及びそれを含む組成物 | |
| CN105324123B (zh) | 激素分泌调节剂、包含该调节剂的组合物、和利用其控制激素分泌的方法 | |
| JP5559087B2 (ja) | 胃腸障害の治療のための方法および組成物 | |
| US7494979B2 (en) | Method for treating congestive heart failure and other disorders | |
| TW505654B (en) | Synthesis of analogs of PTH and PTHrP | |
| JP4334480B2 (ja) | α−ヘリックス安定化剤を用いる高次構造的に制約された副甲状腺ホルモン | |
| Albers et al. | Somatostatin receptor gene expression in neuroblastoma | |
| KR970707141A (ko) | 종양 괴사 인자-감마(Tumor necrosis factor-gamma) | |
| JP2000516579A (ja) | 腸栄養性ｇｌｐ―２ペプチドのアンタゴニスト | |
| JP2001500476A (ja) | 副甲状腺ホルモンに関連する新規ペプチド類似体 | |
| WO2008002971A2 (en) | Methods and compositions for the treatment of gastrointestinal disorders | |
| NZ337955A (en) | Modified TNF-alpha and their use as vaccines | |
| JP2005508944A (ja) | ヒト３レラキシン | |
| Nicolas et al. | Induction of experimental autoimmune orchitis in mice: responses to elevated circulating levels of the activin-binding protein, follistatin | |
| JP2007535466A (ja) | ラクタム架橋を有する、コンホメーションが制限された副甲状腺ホルモン（ｐｔｈ）アナログ | |
| JP2001500845A (ja) | 骨粗鬆症の治寮のための副甲状腺ホルモン類似体 | |
| AU2017225015B2 (en) | Medical Use | |
| SA03230565A (ar) | محفزات مستقبل عامل اطلاق الكورتيكوتروبين -2 | |
| JP2007537980A (ja) | 高次構造的に制約された副甲状腺ホルモン（ｐｔｈ）アナログ | |
| JP2005536453A (ja) | 部分的なペプチド擬似物及び方法 | |
| NZ530985A (en) | Bv8 nucleic acids and polypeptides with mitogenic activity | |
| CA3139956A1 (en) | Anti-mullerian hormone receptor binding peptides | |
| JP2008501632A5 (enExample) | ||
| JP2006517086A (ja) | 副甲状腺ホルモン様ポリペプチド |